New Prevention Options Offer Hope for Children at Risk of Multidrug-Resistant Tuberculosis

New Prevention Options Offer Hope for Children at Risk of Multidrug-Resistant Tuberculosis
5 days ago

In a significant development for global health, children at risk of multidrug-resistant tuberculosis (MDR-TB) can now access preventive treatment options that could save countless lives. This innovative approach marks a crucial step in the fight against tuberculosis, particularly in regions where the disease is prevalent and poses severe risks to the pediatric population.

Continue reading
GSK's RSV Vaccine Demonstrates Long-Lasting Protection Across Multiple Seasons

GSK's RSV Vaccine Demonstrates Long-Lasting Protection Across Multiple Seasons
2 months ago

In a significant development for public health, GlaxoSmithKline (GSK) has announced that its respiratory syncytial virus (RSV) vaccine shows promising durability in its protective effects, extending its efficacy over a remarkable three seasons. This finding is pivotal as RSV poses a substantial risk, particularly for infants and elderly populations, leading to severe respiratory illnesses and hospitalizations each year.

Continue reading